drug
(doxylamine + pyridoxine hydrochloride) DR
Marketedupdated 3mo agoby Duchesnay USA Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying (doxylamine + pyridoxine hydrochloride) DR
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 18, 2033
~6.6 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Feb 18, 2033formulationUS 9089489
- Feb 18, 2033formulationUS 9375404
- Feb 18, 2033formulationUS 9526703
- Feb 18, 2033formulationUS 9937132
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 48m ago
Found something off?
comments(0)
5-min edit window · permanent after that